| 1 |
34056329 | Telmisartan Mitigates TNF-α-Induced Type II Collagen Reduction by Upregulating SOX-9. | 2021 May 4 |
2 |
| 2 |
34281463 | Telmisartan mitigates lipopolysaccharide (LPS)-induced production of mucin 5AC (MUC5AC) through increasing suppressor of cytokine signaling 1 (SOCS1). | 2021 Dec |
2 |
| 3 |
32248168 | The effect of therapy with olmesartan or telmisartan in patients with arterial hypertension combined with obesity. | 2020 |
2 |
| 4 |
33218268 | Obesity and metabolic syndrome related macrophage promotes PD-L1 expression in TNBC through IL6/JAK/STAT pathway and can be reversed by telmisartan. | 2020 Dec 1 |
1 |
| 5 |
23235712 | Effects of telmisartan therapy on interleukin-6 and tumor necrosis factor-alpha levels: a meta-analysis of randomized controlled trials. | 2013 Apr |
5 |
| 6 |
21760473 | Changes in urinary albumin excretion, inflammatory and oxidative stress markers in ADPKD patients with hypertension. | 2012 Jan |
1 |
| 7 |
21700754 | Telmisartan reduces neointima volume and pulse wave velocity 8 months after zotarolimus-eluting stent implantation in hypertensive type 2 diabetic patients. | 2011 Sep |
1 |
| 8 |
18036359 | Comparison of effects of telmisartan and valsartan on late lumen loss and inflammatory markers after sirolimus-eluting stent implantation in hypertensive patients. | 2007 Dec 1 |
1 |